204 related articles for article (PubMed ID: 26707354)
21. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma.
Vaiva G; Ducrocq F; Jezequel K; Averland B; Lestavel P; Brunet A; Marmar CR
Biol Psychiatry; 2003 Nov; 54(9):947-9. PubMed ID: 14573324
[TBL] [Abstract][Full Text] [Related]
22. Blockade of muscarinic receptors impairs reconsolidation of older fear memory by decreasing cholinergic neurotransmission: A study in rat model of PTSD.
Rafiq S; Batool Z; Liaquat L; Haider S
Life Sci; 2020 Sep; 256():118014. PubMed ID: 32593712
[TBL] [Abstract][Full Text] [Related]
23. Effects of propranolol on the modification of trauma memory reconsolidation in PTSD patients: A systematic review and meta-analysis.
Raut SB; Canales JJ; Ravindran M; Eri R; Benedek DM; Ursano RJ; Johnson LR
J Psychiatr Res; 2022 Jun; 150():246-256. PubMed ID: 35405409
[TBL] [Abstract][Full Text] [Related]
24. [Prophylaxis and therapy of post-traumatic stress disorder with propranolol: evidence and ethical analysis].
Kühlmeyer K; Jox RJ
Nervenarzt; 2013 Oct; 84(10):1183-9. PubMed ID: 24036701
[TBL] [Abstract][Full Text] [Related]
25. Determinants of Propranolol's Selective Effect on Loss Aversion.
Sokol-Hessner P; Lackovic SF; Tobe RH; Camerer CF; Leventhal BL; Phelps EA
Psychol Sci; 2015 Jul; 26(7):1123-30. PubMed ID: 26063441
[TBL] [Abstract][Full Text] [Related]
26. Propranolol produces short-term facilitation of extinction in a rabbit model of post-traumatic stress disorder.
Burhans LB; Smith-Bell CA; Schreurs BG
Neuropharmacology; 2018 Jun; 135():386-398. PubMed ID: 29578033
[TBL] [Abstract][Full Text] [Related]
27. Novel combination strategy to optimize treatment for PTSD.
Shad MU; Suris AM; North CS
Hum Psychopharmacol; 2011 Jan; 26(1):4-11. PubMed ID: 21308782
[TBL] [Abstract][Full Text] [Related]
28. Pharmacotherapy for posttraumatic stress disorder.
Stein DJ; Zungu-Dirwayi N; van Der Linden GJ ; Seedat S
Cochrane Database Syst Rev; 2000; (4):CD002795. PubMed ID: 11034765
[TBL] [Abstract][Full Text] [Related]
29. Single dose propranolol does not affect physiologic or emotional reactivity to smoking cues.
Pachas GN; Gilman J; Orr SP; Hoeppner B; Carlini SV; Grasser EB; Loebl T; Nino J; Pitman RK; Evins AE
Psychopharmacology (Berl); 2015 May; 232(9):1619-28. PubMed ID: 25413896
[TBL] [Abstract][Full Text] [Related]
30. Intranasal Oxytocin to Prevent Posttraumatic Stress Disorder Symptoms: A Randomized Controlled Trial in Emergency Department Patients.
van Zuiden M; Frijling JL; Nawijn L; Koch SBJ; Goslings JC; Luitse JS; Biesheuvel TH; Honig A; Veltman DJ; Olff M
Biol Psychiatry; 2017 Jun; 81(12):1030-1040. PubMed ID: 28087128
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of early propranolol administration at reducing PTSD symptoms in pediatric injury patients: a pilot study.
Nugent NR; Christopher NC; Crow JP; Browne L; Ostrowski S; Delahanty DL
J Trauma Stress; 2010 Apr; 23(2):282-7. PubMed ID: 20419738
[TBL] [Abstract][Full Text] [Related]
32. Pharmacotherapy as prophylactic treatment of post-traumatic stress disorder: a review of the literature.
Roque AP
Issues Ment Health Nurs; 2015; 36(9):740-51. PubMed ID: 26440879
[TBL] [Abstract][Full Text] [Related]
33. Effects of beta blockade, PTSD diagnosis, and explicit threat on the extinction and retention of an aversively conditioned response.
Orr SP; Milad MR; Metzger LJ; Lasko NB; Gilbertson MW; Pitman RK
Biol Psychol; 2006 Oct; 73(3):262-71. PubMed ID: 16828533
[TBL] [Abstract][Full Text] [Related]
34. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder.
Bolsoni LM; Crippa JAS; Hallak JEC; Guimarães FS; Zuardi AW
Psychopharmacology (Berl); 2022 May; 239(5):1499-1507. PubMed ID: 35029706
[TBL] [Abstract][Full Text] [Related]
35. Propranolol use in the prevention and treatment of posttraumatic stress disorder in military veterans: forgetting therapy revisited.
Donovan E
Perspect Biol Med; 2010; 53(1):61-74. PubMed ID: 20173296
[TBL] [Abstract][Full Text] [Related]
36. Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescents (Review).
Gillies D; Taylor F; Gray C; O'Brien L; D'Abrew N
Evid Based Child Health; 2013 May; 8(3):1004-116. PubMed ID: 23877914
[TBL] [Abstract][Full Text] [Related]
37. Beta-adrenergic blockade and voice: a double-blind, placebo-controlled trial.
Giddens CL; Barron KW; Clark KF; Warde WD
J Voice; 2010 Jul; 24(4):477-89. PubMed ID: 19846273
[TBL] [Abstract][Full Text] [Related]
38. Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial.
Sack M; Spieler D; Wizelman L; Epple G; Stich J; Zaba M; Schmidt U
BMC Med; 2017 Feb; 15(1):40. PubMed ID: 28209155
[TBL] [Abstract][Full Text] [Related]
39. Dorsal Hippocampal β-Adrenergic System Modulates Recognition Memory Reconsolidation.
Balbinot G; Haubrich J
Neuroscience; 2023 Apr; 516():91-99. PubMed ID: 36858308
[TBL] [Abstract][Full Text] [Related]
40. The Effects of β-Adrenergic Blockade on the Degrading Effects of Eye Movements on Negative Autobiographical Memories.
Littel M; Kenemans JL; Baas JMP; Logemann HNA; Rijken N; Remijn M; Hassink RJ; Engelhard IM; van den Hout MA
Biol Psychiatry; 2017 Oct; 82(8):587-593. PubMed ID: 28456330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
